Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
06/16/2010 | EP2195307A1 Piperazine derivative having affinity for the histamine h3 receptor |
06/16/2010 | EP2195296A1 Quinoline derivatives as 5ht5a receptor antagonists |
06/16/2010 | EP2195029A2 Treatment and prevention of neurodegenerative diseases |
06/16/2010 | EP2195025A1 Therapeutic antibody purification method and method of use |
06/16/2010 | EP2195013A1 Therapeutic use of a growth factor, metrnl |
06/16/2010 | EP2195012A2 Use of a peptide as a therapeutic agent |
06/16/2010 | EP2195007A1 Use of sco-spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands |
06/16/2010 | EP2194986A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
06/16/2010 | EP2194983A1 Compounds which have activity at m1 receptor and their uses in medicine |
06/16/2010 | EP2194982A1 Compounds which have activity at m1 receptor and their uses in medicine |
06/16/2010 | EP2194979A1 Treatment of cns and pain disorders |
06/16/2010 | EP2194975A2 METHODS OF INHIBITING THE FORMATION OF AMYLOID-ß DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
06/16/2010 | EP2194971A1 Pharmaceutical powder compositions comprising a benzodiazepine drug and chitosan |
06/16/2010 | EP2010536B1 Imidazo [1, 2-b]pyridazines, their processes of preparation and their use as gaba receptor ligands |
06/16/2010 | EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
06/16/2010 | EP1784409B1 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
06/16/2010 | EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors |
06/16/2010 | EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine |
06/16/2010 | EP1349857B1 Purine derivatives as purinergic receptor antagonists |
06/16/2010 | EP1307233B1 Therapeutic polyanhydride compounds for drug delivery |
06/16/2010 | CN1960739B Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
06/16/2010 | CN1921847B Amino alcohol compound |
06/16/2010 | CN1886141B T-type calcium channel inhibitor |
06/16/2010 | CN1872846B Method of preparing 2-benzothiazepines derivative |
06/16/2010 | CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase |
06/16/2010 | CN1839124B Succinate and malonate salt of trans-4-(1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
06/16/2010 | CN1839118B Methods and compositions for treating amyloid-related diseases |
06/16/2010 | CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof |
06/16/2010 | CN1805944B Cyclic hydroxylamine as psychoactive compounds |
06/16/2010 | CN1805938B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
06/16/2010 | CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
06/16/2010 | CN1694871B Imidazolopyridines and methods of making and using the same |
06/16/2010 | CN1526409B Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process |
06/16/2010 | CN1500095B Polymer conjugates of neublastin and methods of using ssame |
06/16/2010 | CN101743239A cyanoisoquinoline |
06/16/2010 | CN101743227A Novel histidine derivative |
06/16/2010 | CN101742998A magnesium compositions and uses thereof |
06/16/2010 | CN101742993A Axomadol for treating pain from arthritis |
06/16/2010 | CN101735926A Ginger juice yellow wine |
06/16/2010 | CN101735924A Womb warming youth wine |
06/16/2010 | CN101735922A Aloe rice wine and production technology thereof |
06/16/2010 | CN101735305A Synthesizing method of L-carnosine |
06/16/2010 | CN101735302A Preparation methods of 12 beta-hydroxyl veratroylzygadenine, veratrosine and veratramine, and applications to treating mental diseases |
06/16/2010 | CN101735239A Preparation method of anhydrous olanzapine crystal form II |
06/16/2010 | CN101735235A Compound for preventing amyloid-beta peptide aggregation, and preparation method and application thereof |
06/16/2010 | CN101735230A Bisbenzylisoquinoline derivative and preparation and application thereof |
06/16/2010 | CN101735212A Controlled synthesis of ziprasidone and compositions thereof |
06/16/2010 | CN101735211A Applications of 2,3-dihydro[1,5] benzothiazepine compounds or salts thereof in preparation of GSK-3beta inhibitor |
06/16/2010 | CN101735131A New salts |
06/16/2010 | CN101732713A NOGO-A resisting antibody and extract of ginkgo biloba for treating cerebral apoplexy |
06/16/2010 | CN101732712A NOGO-A resisting antibody and vessel conglutinin inhibitor for treating cerebral apoplexy |
06/16/2010 | CN101732695A Compound of brain protein hydrolyzate and maleic acid and method for preparing same |
06/16/2010 | CN101732665A Externally applied Chinese medicinal spray for pain relieving of cancers and preparation method thereof |
06/16/2010 | CN101732656A Chinese medicament for treating neurasthenia |
06/16/2010 | CN101732646A Capsule for tonifying kidneys and nourishing brain |
06/16/2010 | CN101732627A Chinese medicinal composition for treating insomnia and preparation method thereof |
06/16/2010 | CN101732590A Chinese medicinal preparation for treating migraine |
06/16/2010 | CN101732585A Medicinal composition for treating migraine, preparation method and application thereof |
06/16/2010 | CN101732581A Chinese medicament for treating multiple tourette syndrome |
06/16/2010 | CN101732527A Quality detection method for liver-soothing granules |
06/16/2010 | CN101732524A Medicine composition with functions of narcotizing in operation and alleviating pain after operation |
06/16/2010 | CN101732515A Quality test method of Dianxianning tablets |
06/16/2010 | CN101732503A Treatment formula of brain stem demyelinating diseases and preparation method thereof |
06/16/2010 | CN101732492A Adinandra nitida leaf flavone oral tablet and preparation method |
06/16/2010 | CN101732466A Method for controlling quality of Guipi granules |
06/16/2010 | CN101732461A Composition for improving brain function and/or treating encephalopathy |
06/16/2010 | CN101732458A Compound essential oil having functions of refreshing spirit, restoring consciousness and resisting fatigue, and wet tissue containing same |
06/16/2010 | CN101732439A Chinese medicinal preparation for treating insomnia |
06/16/2010 | CN101732438A Medicine for resisting insomnia and preparation method thereof |
06/16/2010 | CN101732437A Chinese medicinal preparation for treating neurasthenia |
06/16/2010 | CN101732427A Medicinal composition for preventing and/or treating melancholia and climacteric syndrome |
06/16/2010 | CN101732394A Tibetan medicament for treating depression and phrenesis (schizophrenia) and preparation method thereof |
06/16/2010 | CN101732376A Chinese medicament for treating aseptic inflammation and pain |
06/16/2010 | CN101732366A Medicine with function of treating hypertension, hyperlipoidemia, diabetes and sleep disorder |
06/16/2010 | CN101732356A Pus drawing-out paste for treating pain in neck, shoulder, waist and lower extremities |
06/16/2010 | CN101732350A Method for preparing nano pearl powder |
06/16/2010 | CN101732331A Composite of monostalotetrahexosylgangliside and glutamate |
06/16/2010 | CN101732322A Application of corosolic acid in preparation of antidepressant drug |
06/16/2010 | CN101732317A Analgetic composition and application thereof |
06/16/2010 | CN101732314A Composition of naloxone hydrochloride and polyvinylpyrrolidone and preparation method thereof |
06/16/2010 | CN101732313A Medicine composition of naloxone hydrochloride and polyethylene glycol and preparation method thereof |
06/16/2010 | CN101732312A Huperzine A oral formulation and a preparation method thereof |
06/16/2010 | CN101732311A Penfluridol-containing oral preparation and application thereof |
06/16/2010 | CN101732301A Application of chlorogenic acid in preparing medicines for preventing and curing senile dementia |
06/16/2010 | CN101732296A Agomelatine-containing medicinal composition |
06/16/2010 | CN101732295A Idebenone composition for the treatment of neurological disorders |
06/16/2010 | CN101732265A Huperzine-A intra-gastric floating tablet |
06/16/2010 | CN101732261A Stable type compound pellet, preparation method thereof and capsule containing same |
06/16/2010 | CN101732251A Oxiracetam liposome injection |
06/16/2010 | CN101732132A Medical care instrument of ears and brain |
06/16/2010 | CN101731391A Sanqing broadleaf holly leaf |
06/16/2010 | CN101283965B Preparation containing bendopa methyl ester and preparation method thereof |
06/16/2010 | CN101157716B Dicarbon drop freedelane triterpenoid and preparation method and uses thereof |
06/16/2010 | CN101155814B Crystals of morphinan derivative and process for producing the same |
06/16/2010 | CN101120003B Thieno-pyridine derivatives as GABA-B allosteric enhancers |
06/16/2010 | CN101056627B Therapeutic agent for interstitial cystitis |
06/16/2010 | CN101002625B Beverage for relieving summer heat, and its preparing process |
06/15/2010 | US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
06/15/2010 | US7737264 Oligomeric compounds for the modulation HIF-1α expression |
06/15/2010 | US7737161 such as 5-amino-N-(5-chloropyridin-2-yl)-3-{[(trans-4-pyrrolidin-1-ylcyclohexyl)carbonyl]amino}furo[3,2-b]pyridine-2-carboxamide, used as activated blood coagulation factor X inhibitors |